Application 076269
- Type
- ANDA
- Sponsor
- TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 500MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-7267 | Metformin Hydrochloride | Metformin Hydrochloride | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7267 | Metformin Hydrochloride | Metformin Hydrochloride | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0615-5583 | Metformin Hydrochloride | Metformin Hydrochloride | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 42708-075 | Metformin Hydrochloride | Metformin Hydrochloride | QPharma Inc | ANDA | Current |
| 66116-433 | Metformin Hydrochloride | Metformin Hydrochloride | MedVantx, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 8884 | ORIG | 2004-06-21 |